2008
DOI: 10.1016/j.artres.2008.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of pulse wave velocity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
83
0
7

Year Published

2011
2011
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(91 citation statements)
references
References 40 publications
1
83
0
7
Order By: Relevance
“…This distension can be used to produce an optical signal which is correlated with the passing pressure wave. Several studies have shown that the distension and the pressure waveforms have an analogous wave contour and, therefore, can reciprocally be used for pulse wave analysis [9,28,47].…”
Section: Measurement Systemmentioning
confidence: 99%
“…This distension can be used to produce an optical signal which is correlated with the passing pressure wave. Several studies have shown that the distension and the pressure waveforms have an analogous wave contour and, therefore, can reciprocally be used for pulse wave analysis [9,28,47].…”
Section: Measurement Systemmentioning
confidence: 99%
“…The pulse wave is generated by the contraction of the left ventricle, which causes initial shock pulse, counter the blood in the aorta. The pressure wave is recorded at these 2 sites (carotid and femoral) using sensors alternately on the carotid and the femoral site (42). Figure 4 shows the locations and the distance between the carotid and the femoral sites.…”
Section: The Carotid-femoral Pulse Wave Velocitymentioning
confidence: 99%
“…Aortic aging can be evaluated directly by measuring the PWV, using different devices. Pulse wave velocity, measured between carotid and femoral sites, is considered as the gold standard of aortic central aging (18); it is associated with age, hypertension, diabetes, and cholesterol, and also with kidney, heart failure, and cognitive impairment.…”
Section: Arterial Aging and Risk Factorsmentioning
confidence: 99%
“…[15][16][17][18][19][20][21] Although pathophysiologically very important, arterial stiffness is still a surrogate end point and what finally counts for the clinician (and for the patient) is the effect of treatment on cardiovascular morbidity and mortality (as proven in large randomized controlled trials). Therefore, there is still a need for data from prospective short term and long-term studies assessing the effects of the so-called 'cardiovascular protective drugs' on arterial aging and on clinical outcome data, thereby comparing results on the basis of central hemodynamic parameters with results based on peripheral measures.…”
mentioning
confidence: 99%